Study:
A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Dexmedetomidine for Sedation During Monitored Anesthesia Care
Rationale:
n/a
Purpose:
The objective of this study is to evaluate the safety and efficacy of dexmedetomidine as
compared to placebo when used for the sedation of subjects requiring monitored anesthesia
care.
Study Status: Completed
Recruiting:
n/a
| Condition |
Intervention |
Phase |
Anesthesia Surgical Procedures, Elective |
Drug: Dexmedetomidine Drug: Midazolam Drug: Fentanyl |
Phase 3 |
Verified by
Hospira, Inc.
October, 2007
Sponsored by: Hospira, Inc.
Information provided by: Hospira, Inc.
ClinicalTrials.gov identifier: NCT00398827
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Cleveland Clinic Foundation
Cleveland, Ohio 44195
United States
n/a